Colorectal Cancer Trial, Recruiting NCT04751448 Sponsor: Baylor Research Institute Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT04751448
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with colon cancer
  • People who are older than 18 and no more than 79 years of age
  • People who are able to understand and agree to participate by signing a consent form
  • People whose treatment plan includes a chemotherapy combination called FOLFOX

Who may not be able to join:

  • People who are pregnant
  • People who have been diagnosed with Lynch syndrome or FAP (inherited conditions that increase the risk of certain cancers)
  • People who are unable to understand or agree to a consent form
  • People who would not be able to attend or complete the required follow-up appointments
  • People who have previously had colon cancer before the current diagnosis
  • People who have taken antibiotics within the last month
  • People who have previously had part or all of their bowel surgically removed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Baylor Research Institute
Registry
ClinicalTrials.gov
Start date
1 February 2021
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Microbiome-Based Prediction of Chemotherapy-induced Diarrhea in Colon Cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov